SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-026263
Filing Date
2023-02-07
Accepted
2023-02-07 08:19:02
Documents
13
Period of Report
2023-02-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d434599d8k.htm   iXBRL 8-K 24804
2 EX-99.1 d434599dex991.htm EX-99.1 21208
  Complete submission text file 0001193125-23-026263.txt   177734

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20230207.xsd EX-101.SCH 2870
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20230207_lab.xml EX-101.LAB 18756
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20230207_pre.xml EX-101.PRE 11723
7 EXTRACTED XBRL INSTANCE DOCUMENT d434599d8k_htm.xml XML 3526
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 23592860
SIC: 2834 Pharmaceutical Preparations